Title : Novel complex compounds of nickel with 3-(1-phenyl-2,3-dimethyl-pyrazolone-5)azopentadione-2,4: synthesis, NBO analysis, reactivity descriptors and in silico and in vitro anti-cancer and bioactivity studies - Tahirli_2024_J.Biomol.Struct.Dyn__1 |
Author(s) : Tahirli S , Aliyeva F , Senol H , Demukhamedova S , Akverdieva G , Aliyeva I , Veysova S , Sadeghian N , Gunay S , Erden Y , Taslimi P , Sujayev A , Chiragov F |
Ref : J Biomol Struct Dyn , :1 , 2024 |
Abstract :
A synthesized azo compound based on 4-amino antipyrine and its complexes with Ni(II) in solution and solid phase is reported. The structures of these compounds have been testified by IR and NMR spectroscopy. The combined experimental and theoretical approach was used. To study the structure and properties of the synthesized compound, as well as its possible complex formation with the Ni(II), ab initio quantum-chemical calculations were carried out using the Hartree-Fock (HF) method with the 6-31 G basis set and the electron density functional theory (DFT) method with hybrid three-parameter potential B3LYP and extended basis set 6-311++G(d,p) taking into account polarization and diffuse functions for all atoms. The geometric, energy, and electronic parameters were calculated and analyzed. The HOMO-LUMO energy gap has been calculated to determine chemical activity. Both complexes had effective inhibition against butyrylcholinesterase and acetylcholinesterase. IC50 values were found as 19.43 and 27.08 microM for AChE, 2.37 and 7.40 microM for BChE, respectively. For the anticancer outcome, high doses of compound E1 inhibited viability by about 40-45%, while this rate was around 65-70% for compound E2 at the same doses. Anticholinesterase and anticancer potential of compounds E1 and E2 also evaluated by in silico techniques. Both compounds show strong binding to VEGFR1, with E2 exhibiting superior inhibitory activity in hAChE and hBChE through shorter and stronger interactions. MD simulations suggest that E2 forms more stable complexes with hAChE and hBChE compared to E1, making it a promising candidate for further exploration in anticancer and anticholinesterase therapies.Communicated by Ramaswamy H. Sarma. |
PubMedSearch : Tahirli_2024_J.Biomol.Struct.Dyn__1 |
PubMedID: 38294759 |
Tahirli S, Aliyeva F, Senol H, Demukhamedova S, Akverdieva G, Aliyeva I, Veysova S, Sadeghian N, Gunay S, Erden Y, Taslimi P, Sujayev A, Chiragov F (2024)
Novel complex compounds of nickel with 3-(1-phenyl-2,3-dimethyl-pyrazolone-5)azopentadione-2,4: synthesis, NBO analysis, reactivity descriptors and in silico and in vitro anti-cancer and bioactivity studies
J Biomol Struct Dyn
:1
Tahirli S, Aliyeva F, Senol H, Demukhamedova S, Akverdieva G, Aliyeva I, Veysova S, Sadeghian N, Gunay S, Erden Y, Taslimi P, Sujayev A, Chiragov F (2024)
J Biomol Struct Dyn
:1